Showing results (1141-1150 of 2,811) with videos related to

Sort By:
Pageof 282
Expert Opinion on Drug Safety|April 2, 2020
How is safety of dermatology drugs assessed: trials, registries, and spontaneous reportingLeila Asfour, Zenas Z N Yiu, Richard B Warren
Expert Opinion on Drug Safety|November 27, 2020
Safety considerations of current drug treatment strategies for nosocomial pneumoniaAdrian Ceccato, Pierluigi Di Giannatale, Stefano Nogas, et al.
Expert Opinion on Drug Safety|February 23, 2018
The safety of gliptins : updated data in 2018André Jacques Scheen
Expert Opinion on Drug Safety|September 23, 2014
How safe is infliximab therapy during pregnancy and lactation in inflammatory bowel disease?María Chaparro, Javier P Gisbert
Expert Opinion on Drug Safety|July 9, 2014
Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access programDaniel Castellano, Luis M Antón Aparicio, Emilio Esteban, et al.
Expert Opinion on Drug Safety|August 30, 2014
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of ItalyElisabetta Parretta, Concetta Rafaniello, Lara Magro, et al.
Expert Opinion on Drug Safety|August 30, 2014
Adherence to therapy and adverse drug reactions: is there a link?Christian Leporini, Giovambattista De Sarro, Emilio Russo
Expert Opinion on Drug Safety|August 30, 2014
DPP-4 inhibitors: pharmacological differences and their clinical implicationsAntonio Ceriello, Liberata Sportiello, Concetta Rafaniello, et al.
Expert Opinion on Drug Safety|May 5, 2016
Safety of insulin analogues as compared with human insulin in pregnancyYoel Toledano, Eran Hadar, Moshe Hod
Pageof 282